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Abstract
The analysis of less common variants in genome-wide association studies promises to elucidate complex trait genetics but is
hampered by low power to reliably detect association. We show that addition of population-specific exome sequence data
to global reference data allows more accurate imputation, particularly of less common SNPs (minor allele frequency 1–10%)
in two very different European populations. The imputation improvement corresponds to an increase in effective sample
size of 28–38%, for SNPs with a minor allele frequency in the range 1–3%.
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Introduction
Genome-wide association study (GWAS) meta-analyses rou-
tinely use genotype imputation [1]. Accurate imputation of less
common variants (minor allele frequency MAF, 1–10%) may be
particularly useful as commercial genotyping arrays often provide
poor coverage of such variants, and imputation improves
association power most for less frequent causal variants [2].
The recently released 1000 Genomes haplotypes [3] are a
particularly large and dense reference panel that will be commonly
used as an imputation reference panel, particularly in GWAS
consortia. At the same time, theoretical studies and empirical
studies using other primary reference panels, have shown that
imputation accuracy in a study population can be increased by use
of an additional reference panel such as whole genome or exome
sequence data drawn from a subset of the population under study
[2] [4] [5] [6] [7] [8] [9].
It is therefore useful to quantify the likely benefit of adding local
reference data to 1000 Genomes data, particularly for less
common variants, and especially if the population is genetically
distant from the 1000 Genomes populations.
We used data from the CROATIA-Korcula and Orkney
Complex Disease studies (ORCADES) [10] [11]. Both studies are
family-based, cross-sectional community studies of the genetics of
complex traits. The Croatian island of Korcˇula is in the Adriatic
and the ORCADES study is based in the Orkney Isles in Scotland.
Genotypes obtained from the whole exome sequencing of 91/89
CROATIA-Korcula/ORCADES quality controlled samples were
used to supplement the 1000 Genomes reference panel. We
focused on less common (MAF 1–10%) exonic variants already in
1000 Genomes which, unlike low frequency, and rare (MAF,1%)
or private variants, can be meta-analyzed in typically sized
consortia.
In this paper, we therefore seek to determine if imputation
accuracy can be improved by the addition of local sequences to a
global reference panel.
Methods
The ORCADES and CROATIA-Korcula studies both had
ethical approval for genetic research into the basis of complex
traits, approved by the appropriate committees in each country.
For ORCADES the committees were the Orkney Local Research
Committee and the North of Scotland Research Ethics Committee
(approval Orkney: 27/2/04). For CROATIA-Korcula the com-
mittees were the Ethics Committee of the Medical School,
University of Split (approval id 2181-198-03-04/10-11-0008) and
the NHS Lothian (South East Scotland Research Ethics Commit-
tees; REC reference 11/AL/0222). All participants provided
written informed consent.
Array genotypes were obtained from Illumina Hap370CNV
array, at 319,552 SNPs for CROATIA-Korcula subjects and
Illumina Omni1 array at 1,140,419 SNPs or the Illumina Human
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Hap300 array at 293,687 SNPs for ORCADES subjects. For
ORCADES a common panel of intersecting Hap300 and Omni1
SNPs was first created. The panel for CROATIA-Korcula was
then restricted to these SNPs, to ensure similar panel sizes.
Subjects to be sequenced were selected from the wider study
populations that were genotyped on the Illumina Hap (370CNV/
300) arrays to minimize relatedness, and thus to maximize
representation of study population haplotypes. The selection was
carried out by tracking the identity-by-descent sharing structure,
as determined by the array genotypes using the program
ANCHAP [12]. Whole exome sequences of 99/95 CROATIA-
Korcula/ORCADES subjects were generated using the Agilent
SureSelect All Exon 50 Mb kit and 234,746/217,015 variants
were identified.
Quality control (QC) of genotyping array data, that were
subsequently used for imputation, was in accordance with best
practice for association studies [13] and is described in detail in
Methods S1. As illustrated in Figure 1, post QC array data of
170,134/171,749 SNPs for 892/1158 Korcˇulan/Orcadian sub-
jects were then pre-phased simultaneously (within each popula-
tion) using SHAPEIT v1.r416 [14] [15] including the maximal
pedigree structure permitted by the software (non-overlapping
nuclear families) to create a phased set of study genotypes ready for
imputation using IMPUTE2 v2.2.2 [16]. The simultaneous
phasing of all (892/1158) study subjects allowed all these subjects’
phasing to inform the phase of the ,100 subjects taken forward as
a reference panel and for imputation.
Exome sequence data were also subjected to rigorous QC to
ensure they were of high quality so that that the local reference
panel we created did not have a significant number of incorrect
haplotypes. Variants were called by first aligning the raw sequence
data to the human hg19 reference genome using the Stampy short
read aligner [17] (with BWA utilized as a pre-mapper [18]).
Genotype calls were produced from the resulting alignments using
GATK’s unified genotyper, following GATK’s recommended best
practice for variant detection from exome sequence datasets [19].
Variants were required to have a phred-scaled quality of at least
40. Individual sample genotype calls with a phred-scaled quality
less than 20 were regarded as missing. Variants that were called in
less than 50% of subjects, or with a minor allele frequency of less
than 0.75% were removed (hence inclusion required at least two
minor alleles across samples). All variants that mapped to more
than one homologous region or failed a test of Hardy-Weinberg
equilibrium (HWE) with a p-value of less than 1024, were also
removed, leaving 99/95 CROATIA-Korcula/ORCADES sub-
jects genotyped for 102,192/97,052 variants. The HWE test was a
more stringent test than for the array data reflecting lower sample
numbers and the desire to particularly ensure integrity for
reference data. We restricted our analysis to individuals with
exome sequences and merged the exomes with the array data for
these subjects. Subjects/variants with more than 50/30 mismatch-
ing calls, between the array and sequence data were excluded,
although no variants failed this test. This resulted in exomes for
93/90 subjects genotyped at 102,192/97,052 exonic SNPs being
merged with array data at 170,134/171,749 SNPs for these
individuals. The resulting panels had 265,929/262,513 variants
which were 99.91%/99.92% concordant, based on the genotypes
called on both panels for 6,397/6,285 overlapping variants. As the
overall genotypic concordance could mask discrepancies for minor
alleles, particularly the less common variants of interest, concor-
dance rates for minor allele calls were calculated in the MAF 1–
3% range separately. Only 1/1 (CROATIA-Korcula/OR-
CADES) call was discrepant on each overlapping panel, giving
minor allele concordance of 99.7% in both studies for these
variants.
8,150/10,964 Korcˇulan/Orcadian variants other than single
base substitutions, for example insertions or deletions, were
excluded. 119/110 conflicting map positions and individuals
called at fewer than 80% of the combined SNP panel were then
excluded, leaving 91/89 subjects typed across 257,633/251,439
SNPs. Our focus was on the potential to improve power in meta-
analyses, so polymorphisms that were unique to each cohort were
excluded. This was done by comparison to the 1000 Genomes
project map and those variants not present in the 1000 Genomes
reference data or with mismatches in allele codes were excluded.
The merged sequence and array data consisting of 233,195/
232,096 variants for 91/89 subjects were then phased by
SHAPEIT, using the recommended Ne of 11,418 and the default
settings [14], to create reference haplotypes, as shown in the lower
half of Figure 1.
Having created suitable post-QC array data and secondary
reference panels, imputations were performed using genome-wide
array data plus (i) 1000 Genomes haplotypes [2] alone or (ii) 1000
Genomes haplotypes together with local data as reference panels.
Both imputations were then compared with known genotypes and
an assessment of accuracy across all subjects was made for each
SNP, as illustrated in Figure 2.
Imputation of the 91/89 subjects with and without the benefit of
local reference data was carried out using IMPUTE2, using the
phased reference panel option, the phased array data haplotype
option, and with the software splitting the genome into chunks,
which had been predetermined to be less than 5 Mb in size and
avoiding crossing the centromeres. Ne was set to 20,000; all other
settings were left at their default values. For the one panel
Figure 1. Preparation of array data and local reference panel for imputation. The genotype data were quality controlled and phased. These
data were then used in further downstream analysis.
doi:10.1371/journal.pone.0068604.g001
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imputation, the 1000 Genomes Phase 1 worldwide integrated
variant set (March 2012 release) [3] as available on the IMPUTE2
website [16] was used. The two-panel imputation added the
phased local reference data as a secondary panel (we did not use
the merge panels option). All other settings for the two-panel
imputation we were identical to the one panel imputation. We
performed imputations for each subject with local exome data
separately, with the study subject’s own haplotypes removed from
the secondary reference panel so that the haplotypes of the
individual to be imputed were not present in the reference data.
For a given SNP, the accuracy (r2) of the allelic dosages imputed
was measured across samples against the known exome sequence-
called genotypes.
As evidenced by the genome-wide SNP array concordance data,
noted above, there was close agreement between the exome
sequence and independent genotyping data, indicating that the
sequences were a suitable gold standard. Furthermore exome
array data were also available for the CROATIA-Korcula study
(although not ORCADES) and concordance between exome array
and exome sequence genotypes was 99.5% and was similar across
all MAF bands.
The dual use of exome sequences both as a secondary reference
panel and as the gold standard to obtain imputation accuracy was
considered appropriate since a subject’s imputation panel did not
include their own sequence, avoiding circularity at the imputation
stage.
Results
We found a significant increase in accuracy (r2 of imputed
against known allele dosages across samples for a given SNP) from
use of a local reference panel, which was often substantial for less
common variants (Table 1).
Variants with a minor allele frequency in the range 0.01–0.032
showed an increase in imputation accuracy of 0.193/0.167 (38%/
28% improvement) for CROATIA-Korcula/ORCADES and
0.112/0.089 (15%/11% improvement) for variants with MAF
between 0.032 and 0.100. The high accuracy of the 1000
Genomes imputation for more common variants (MAF .0.1)
provided more limited scope for improvement in this category,
although even for the most common variants (MAF.0.32) the
accuracy of imputation increased by 0.039/0.031 (4%/3%
improvement) for CROATIA-Korcula/ORCADES after adding
the second (local) reference panel.
Much of the improvements arise from SNPs that have an r2
close to zero with the 1000 Genomes-only imputation and which
were imputed more accurately with the addition of the local panel
(Figure 3). For CROATIA-Korcula/ORCADES 12%/9% of all
SNPs imputed poorly (r2,0.2) using 1000 Genomes data alone.
About one-fifth (17.1%/19.9%) of these poorly imputed SNPs
imputed well (r2.0.8) after the addition of the local reference
panel.
SNPs that were less frequent in 1000 Genomes than in our
sequences generally improved more, as illustrated in Figure 4,
where areas of greater improvement are generally observed
towards the right-hand side in the figure. The effect is more
pronounced in Korcˇula and is particularly marked for variants
where MAF is less than 1% on 1000 Genomes European panel.
Counts of the SNPs in each cell of Figure 4 are shown in table
S1.
We also looked at r2 increase as a function of European 1000
Genomes MAF. As stated above, for SNPs with a MAF of 1–3.2%
in our local sequences, the mean increase in r2 was 0.193/0.167.
For these SNPs, the increase in r2 was 0.297/0.264 for those in the
European 1000 Genomes MAF band,1%, 0.137/0.112 for MAF
band 1–3.2% and 0.086/0.072 for MAF .3.2%.
Discussion
Our results show that use of a secondary local reference panel in
addition to the 1000 Genomes reference haplotype data can
significantly increase the quality of imputations, particularly for
less common alleles and the improvement is greater when the
study population is genetically further from the populations in the
reference data.
We estimated imputation accuracy using a leave-one-out cross-
validation approach, in which we compared known genotypes to
imputed ones using either the 1000 Genomes reference panel
alone or accompanied by a panel obtained from sequence data of
individuals from our study populations. Although we took care in
Figure 2. Illustration of the procedure to estimate imputation accuracy. We used a drop one-out crossvalidation approach. For the
imputation step each subject was removed from the reference panel in turn, and this subject’s exome sequence SNPs were then imputed using either
the 1000 Genomes reference panel alone or in conjunction with a second local reference panel. All subjects’ imputed allelic dosages were then
compared with the exome sequence genotype data (‘‘gold standard’’).
doi:10.1371/journal.pone.0068604.g002
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our cross-validations to avoid circularity by using the leave-one-
out approach in the imputations, for practical reasons, especially
computing time, the phasing stage was done only once including
all subjects (and therefore included the subject being blinded at the
imputation stage). We acknowledge that this could potentially
slightly inflate the reported increase in accuracy when using the
second reference panel.
Imputation accuracy is not only affected by the quality and
composition of the reference data used, but also by the design of
the genotyping array, in particular array density and whether the
array captures population specific variants [20]. A dense, locally
relevant array used to genotype the study population will improve
the quality of imputation compared to a less dense one, when
using a global reference panel, and thus reduce the potential scope
for improvement when adding local sequence data. However,
where the study population’s haplotypes are distinct, due to
recombination, from the reference panel population, the use of a
denser array can be expected to improve the imputation but the
denser array will also allow even better matching of local
haplotypes, and so there should be a further benefit from use of
a local secondary reference panel.
Consistent with this hypothesis, the accuracy of base imputa-
tions using only the 1000 Genomes reference panel was greater for
ORCADES than CROATIA-Korcula, presumably due to the
greater proximity of Orkney to subjects in the 1000 Genomes
reference panel. Twenty three Orcadians, 77 mainland British and
Table 1. Mean accuracy of imputation (r2 of allelic dosage across all samples for a SNP) averaged across SNPs split by Minor Allele
Frequency (MAF).
MAF 1–3.2% 3.2–10% 10–32% .32%
Population Korcˇula Orkney Korcˇula Orkney Korcˇula Orkney Korcˇula Orkney
N SNPs 12132 12123 11548 10677 16243 15262 10174 9265
r2 1kG 0.504 0.586 0.729 0.778 0.868 0.894 0.894 0.913
r2 1kG+LRP 0.697 0.753 0.841 0.867 0.916 0.931 0.934 0.944
Increase r2 0.193 0.167 0.112 0.089 0.049 0.037 0.039 0.031
Std dev. 0.309 0.295 0.182 0.157 0.093 0.078 0.074 0.065
Inc. Sample 38% 28% 15% 11% 6% 4% 4% 1%
MAF bins increase by factors of !10, to create four exponentially increasing bins.
N SNPs: number of SNPs in MAF bin.
1kG: 1000 Genomes used as reference panel.
1kG+LRP: 1000 Genomes plus local reference panel.
Increase r2: Average across all SNPs in MAF bin increase in r2.
Std dev: The standard deviation (across SNPs) of the increase in r2 at each SNP.
Inc. Sample: Increase in effective sample size for GWAS.
The standard errors of mean increases are less than 0.003. All improvements in r2 are significantly different from zero and significantly different between MAF bands
(P,0.001, two-sided t tests).
doi:10.1371/journal.pone.0068604.t001
Figure 3. Frequency plot of imputation accuracy (r2) using 1000 Genomes data alone against 1000 Genomes plus a local reference
panel for SNPs with Minor Allele Frequencies (MAF) of 1–3.2%.
doi:10.1371/journal.pone.0068604.g003
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100 of northern European ancestry individuals are present in the
1000 Genomes data, and principal component analysis shows that
Balkan populations (such as Korcˇula) are more distant from the
nearest subjects in 1000 Genomes (Tuscans, from central Italy,
N = 100), than the variation observed within the British Isles [3]
[21]. This suggests to us that, as might be expected, imputation
improvement due to addition of local data will be most marked for
populations genetically distant from 1000 Genomes samples.
Whilst part of the benefit arises from including reference data with
allele frequencies closer to the study population, the capture of
representative local haplotypes further contributes to the increase
in imputation accuracy, and this latter effect will be more marked,
or at least require fewer local subject to be sequenced, in isolated
populations, where fewer distinct haplotypes will be segregating.
Similarly the much greater improvements in accuracy for SNPs
where the MAF is greater in our sequences than 1000 genomes,
perhaps not surprisingly, shows that local sequences will add value
to imputations in regions of the genome where drift, or other
forces, have created a distinct genetic structure.
Comparing these results with those of other researchers who
have examined the benefits of study specific reference panels, often
using 1000 Genomes like us or HapMap [22] as primary panels,
whilst illuminating, is not straightforward. Inevitably, different
types and sizes of reference panels are used, as well as different
genotyping arrays for the subjects whose genotypes are to be
imputed. This is further complicated by different study protocols
and differing genetic structure of the study populations. With these
caveats, our results of an r2 of 0.70–0.75 from 90 reference panel
subjects in addition to 1000 Genomes seem consistent with those
of Liu et al [9] and Auer et al [8], for MAF 1–3%. Neither of these
studies used a global reference panel, but Liu et al, in their
verification step, attained an r2 of around 80% with ,2,000
subjects on their (array data) reference panel with unfiltered
results, whilst Auer et al obtained an r2 of 82% with 761 exome
reference panel subjects, albeit filtering out lower quality results,
using an Rsq threshold of 0.8, where Rsq is equivalent to the
squared correlation between nearby imputed and genotyped SNPs
[8]. Furthermore the latter study demonstrated that the use of
exome imputation can reveal genome-wide significant associa-
tions, not discovered by conventional genotyping arrays, as did the
study by Holm et al [23], who were able to discern a local rare
variant causing sick sinus syndrome, in a large Icelandic study, due
to the benefit of adding 87 whole genome sequences to the
reference data for their imputation.
Many aspects of our study were similar to a study by Surakka
et al [6]. Their Finnish study used 200 (CEU+TSI) HapMap [22]
subjects as their primary reference panel and added 81 local
subjects genotyped by a genome wide array. For alleles with a
MAF ,5%, they obtained a median r2 of 90% for their global
panel only imputation rising to 94% after the addition of their
local panel. In our study, we report mean r2, but our median r2
was 0.77/0.83 rising to 0.88/0.92 after adding the local reference
panel for CROATIA-Korcula/ORCADES for a MAF bucket 3–
5%. The choice of a 3–5% MAF is intended to correspond to
typical array SNPs with MAF,5%. Our results therefore appear
consistent with the results of Surakka et al. despite the differences
in study design. The study by Uricchio et al [7] obtained much
higher mean r2 (99%), and the technique used for imputation,
identifying runs of identity-by-descent (IBD), should be particu-
larly accurate, but its application is restricted to populations which
share long haplotypes to a much greater extent than is common in
most genetic studies, and we therefore feel our strategy of using
1000 Genomes reference data and adding sequence data from a
subset of one’s own study subjects is a good practical way forward
for many studies.
A proportionate increase in r2 has the same effect on power as a
corresponding increase in study size [24] so the use of high quality
sequence data has the potential to provide substantially greater
power in GWAS studies for less common variants, particularly
those very poorly imputed using 1000 Genomes alone but well
imputed with the addition of local exome sequence data.
Our study focused on the exome, but the results should extend
to any other genomic region of interest. Moreover, the similar
Figure 4. Plot of mean improvement in imputation accuracy (r2) for SNPs with minor allele frequency (MAF) in the range 1–10% in
our exome sequence data.
doi:10.1371/journal.pone.0068604.g004
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results obtained in our study for two independent populations
suggest that corresponding benefits will be found in other studies.
The meta-analysis of multiple populations imputed using local
exome sequence data will likely identify new SNP associations.
However the amount of variance explained by less common
variants individually is likely to be small and will make their
detection challenging. This will put increasing emphasis on the use
of analytical methods that consider jointly groups of variants, be it
gene [25], regional heritability [26] or network based analyses
[27]. Such analyses can also incorporate the potentially valuable
information provided by variants private to individual populations
including the 24,438/19,343 variants identified by the exome
sequencing of the CROATIA-Korcula and ORCADES samples
that are not present in 1000 Genomes and hence we have not
considered here.
Given the cost and significant practical difficulties in subject
recruitment, sequencing a subset of cohort members, for either
part or all of the genome, and using these results for imputation
will provide significant added value to association studies.
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